Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05881252 · ClinicalTrials.gov registry record

Perinatal Outcomes Following Change in Clinical Criteria in for Treatment of Maternal Hypertension

A clinical trial, sponsored by The University of Texas Health Science Center, Houston.

Completed
Registry status
1,003
Enrollment target

NCT05881252 is a clinical trial that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 1,003 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05881252 has completed, sponsored by The University of Texas Health Science Center, Houston.

COMPLETED
Registry status
1,003 participants
Enrollment target

Study Summary

The purpose of this study is observe outcomes before and after a change in clinical practice in the threshold for management of severe hypertension in pregnancy and the post-partum period. Outcomes will be observed for 10 months under the current (traditional) clinical blood pressure threshold for acute treatment of hypertension, which is \>= 160 millimeters of mercury (mmHg) systolic blood pressure (SBP). This will be followed by one month of education about rationale for the new SBP threshold of \>= 180 mmHg and change of clinical guidelines. Then, there will be 10 months of observation after adopting the updated clinical threshold for acute antihypertensive treatment (\>= 180 SBP).

Interventions

  • PROCEDURE Clinical blood pressure threshold of SBP >= 160 mmHg for acute treatment of hypertension
  • PROCEDURE Clinical blood pressure threshold of SBP >= 180 mmHg for acute treatment of hypertension

Trial Details

FieldValue
Enrollment Target 1,003 participants
Start Date 2023-05-11
Est. Completion 2024-04-04

What the Registry Record Tells You About NCT05881252

The ClinicalTrials.gov registry entry for NCT05881252 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,003 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Clinical blood pressure threshold of SBP >= 160 mmHg for acute treatment of hypertension is the first listed.

NCT05881252 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05881252 about?

NCT05881252 is a clinical study titled "Perinatal Outcomes Following Change in Clinical Criteria in for Treatment of Maternal Hypertension". The purpose of this study is observe outcomes before and after a change in clinical practice in the threshold for management of severe hypertension in pregnancy and the post-partum period. Outcomes will be observed for 10 months under the current (traditional) clinical blood pressure threshold for a...

What is the current status of trial NCT05881252?

This trial is currently completed. The enrollment target is 1,003 participants. The study started on 2023-05-11. Estimated completion is 2024-04-04.

What interventions are being tested in trial NCT05881252?

The interventions under investigation include: Clinical blood pressure threshold of SBP >= 160 mmHg for acute treatment of hypertension (PROCEDURE), Clinical blood pressure threshold of SBP >= 180 mmHg for acute treatment of hypertension (PROCEDURE).

Who is sponsoring clinical trial NCT05881252?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.